A continuous closed-loop insulin delivery system using subcutaneous insulin delivery was evaluated in eight dia-betic canines. Continuous glucose profiles were obtained by extrapolation of blood glucose measurements. Insulin delivery rate was calculated, using a model of -cell insulin secretion, and delivered with a Medtronic MiniMed subcu-taneous infusion pump. The model acts like a classic pro-portional-integral-derivative controller, delivering insulin in proportion to glucose above target, history of past glucose values, and glucose rate of change. For each dog, a proportional gain was set relative to the open-loop total daily dose (TDD) of insulin. Additional gains based on 0.5 TDD and 1.5 TDD were also evaluated (gain dose response)...
This thesis describes the stepwise development and testing of the components of a novel artificial e...
grantor: University of TorontoIn our previous studies in normal dogs and humans, insulin ...
BackgroundFor the treatment of diabetes mellitus (DM) in dogs, novel insulins with decreased injecti...
An automated closed-loop insulin delivery system based on subcutaneous glucose sensing and subcutane...
Physiological hyperinsulinemia provokes hemodynamic ac-tions and augments access of macromolecules t...
Ann Thompson,1 Patty Lathan,2 Linda Fleeman3 1School of Veterinary Science, The University of Queens...
Skeletal muscle accounts for a large proportion of insulin-stimulated glucose utilization. It is gen...
Objective: The goal of this study was to develop a unified physiological subcutaneous (SC) insulin a...
Invited Review ArticleObjective: Present a new model-based tight glycaemic control approach using va...
Highly informative yet simple protocols to assess insulin secretion and action would considerably en...
Copyright © 2013 Nils K. Skjaervold et al. This is an open access article distributed under the Crea...
Studies were conducted in conscious 42-h–fasted dogs to determine how much of insulin’s effect on he...
OBJECTIVE—To characterize differences in whole-body glu cose metabolism between commonly used inbred...
The use of rapid-acting insulin analogs as routes of administration other than IV has never been des...
Bolus infusion of insulin along with a meal is a standard procedure with continuous subcutaneous ins...
This thesis describes the stepwise development and testing of the components of a novel artificial e...
grantor: University of TorontoIn our previous studies in normal dogs and humans, insulin ...
BackgroundFor the treatment of diabetes mellitus (DM) in dogs, novel insulins with decreased injecti...
An automated closed-loop insulin delivery system based on subcutaneous glucose sensing and subcutane...
Physiological hyperinsulinemia provokes hemodynamic ac-tions and augments access of macromolecules t...
Ann Thompson,1 Patty Lathan,2 Linda Fleeman3 1School of Veterinary Science, The University of Queens...
Skeletal muscle accounts for a large proportion of insulin-stimulated glucose utilization. It is gen...
Objective: The goal of this study was to develop a unified physiological subcutaneous (SC) insulin a...
Invited Review ArticleObjective: Present a new model-based tight glycaemic control approach using va...
Highly informative yet simple protocols to assess insulin secretion and action would considerably en...
Copyright © 2013 Nils K. Skjaervold et al. This is an open access article distributed under the Crea...
Studies were conducted in conscious 42-h–fasted dogs to determine how much of insulin’s effect on he...
OBJECTIVE—To characterize differences in whole-body glu cose metabolism between commonly used inbred...
The use of rapid-acting insulin analogs as routes of administration other than IV has never been des...
Bolus infusion of insulin along with a meal is a standard procedure with continuous subcutaneous ins...
This thesis describes the stepwise development and testing of the components of a novel artificial e...
grantor: University of TorontoIn our previous studies in normal dogs and humans, insulin ...
BackgroundFor the treatment of diabetes mellitus (DM) in dogs, novel insulins with decreased injecti...